Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

August 12, 2022

Conditions
IGT - Impaired Glucose ToleranceT2D
Interventions
DIAGNOSTIC_TEST

Oral Glucose Tolerance Test

The oral glucose tolerance test (OGTT) measures the body's ability to use a type of sugar, called glucose, that is the body's main source of energy. An OGTT can be used to diagnose prediabetes and diabetes.

DIAGNOSTIC_TEST

Hyperglycemic Clamp

Test of beta-cell function and insulin secretion. Involves increasing and maintaining blood glucose concentration with IV variable infusion of dextrose.

DIAGNOSTIC_TEST

Isoglycemic Intravenous Glucose Test

Test which exposes pancreas to blood glucose levels matched to the ones obtained at the OGTT.

DIAGNOSTIC_TEST

Hyperinsulinemic Euglycemic Clamp and 2H20

Test is used to assess insulin effects on hepatic glucose production.

Trial Locations (1)

06510

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER

NCT03195400 - Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes | Biotech Hunter | Biotech Hunter